Petros Pharmaceuticals Inc (NASDAQ: PTPI): Stock Forecast For 2024 Remains Weak With A Downward Revision Of 35.3%

In the last trading session, 1.28 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.11. Most recently the company’s share price was $0.35, and it changed around $0.04 or 12.90% from the last close, which brings the market valuation of the company to $3.96M. PTPI currently trades at a discount to its 52-week high of $2.27, offering almost -548.57% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 37.14% since then. We note from Petros Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 8.87 million shares, with the 3-month average coming to 1.59 million.

Petros Pharmaceuticals Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PTPI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Petros Pharmaceuticals Inc is expected to report earnings per share of 0 for the current quarter.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Instantly PTPI has showed a green trend with a performance of 12.90% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3777 on recent trading dayincreased the stock’s daily price by 7.33%. The company’s shares are currently down -75.11% year-to-date, but still up 12.43% over the last five days. On the other hand, Petros Pharmaceuticals Inc (NASDAQ:PTPI) is 31.08% up in the 30-day period. We can see from the shorts that 0.2 million shares have been sold at a short interest cover period of 0.72 day(s).

PTPI Dividends

Petros Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 8.10% of Petros Pharmaceuticals Inc shares, and 2.29% of them are in the hands of institutional investors. The stock currently has a share float of 2.49%.